Acute Pancreatitis Market could be worth US$ 8,827.37 million by 2030, says Premium Market Insights

Acute Pancreatitis Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Coverage: Offerings (Medications, Diagnosis, and Others), Causes (Gallstones, Alcoholism, Genetic Disorders, Infection, and Others), End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa) The acute pancreatitis market size is expected to reach US$ 8,827.37 million by 2030 from US$ 5,649.77 million in 2022; it is estimated to record a CAGR of 5.7% from 2022 to 2030.

Get PDF Sample Report + All Related Table and Graphs @: https://www.premiummarketinsights.com/sample/TIP00074079?utm_source=OpenPR&utm_medium=10823

Competitive Landscape: Acute Pancreatitis Market:
The pancreas produces insulin, a hormone that regulates blood sugar levels. Pancreatitis can harm insulin-producing cells of pancreas, which causes diabetes in patients suffering from acute pancreatitis. People suffering from acute pancreatitis are at a twofold greater risk of diabetes as compared to the general population. The World Health Organization (WHO) American Diabetes Association has classified the development of diabetes after acute pancreatitis as exocrine pancreatic diabetes (pancreatogenic diabetes). Pancreatogenic diabetes is increasingly being linked to exocrine disorders of the pancreas. Diabetes sequelae are observed across the spectrum of severity in acute pancreatitis and can accompany other clinical complications.
As per the European Review for Medical and Pharmacological Sciences, published in 2022, the prevalence of pancreatogenic diabetes is 5-10% in the Western diabetic population, and chronic pancreatitis is responsible for 20% of cases while acute pancreatitis causes 80% of cases. According to an article published in the National Library of Medicine in 2021, ~23% of acute pancreatitis patients are likely to develop diabetes within three years of discharge. Further, an article published in the Journal of Gastroenterology in 2020 states that following acute pancreatitis, ~3%, 7%, 9%, and 11% of patients develop diabetes at 6, 12, 18, and 24 months of discharge, respectively. According to an article published in the MDPI, in 2023, ~40% of patients with acute pancreatitis are affected by prediabetes and diabetes, and are at a higher risk of death and readmission to hospitals than patients with type 2 diabetes. Further, ~ 60.2% of adult patients developed diabetes after acute pancreatitis, and 9% of children after acute recurrent pancreatitis or with chronic pancreatitis, and this risk increases as they age into adulthood. Researchers have noted higher diabetes incidence (~39%) after severe acute pancreatitis than mild acute pancreatitis (14%) in a meta-analysis comparing severe and mild acute pancreatitis.Campbell Soup Company

Abbott Laboratories
GE HealthCare Technologies Inc
Samsung Healthcare
Koninklijke Philips NV
Baxter International Inc
Dynavax Technologies Corp
Actim Oy
Medtronic Plc
Boston Scientific Corp
Fresenius Kabi AG

Chapter Details of Acute Pancreatitis Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Acute Pancreatitis Market Landscape
Part 04: Acute Pancreatitis Market Sizing
Part 05: Acute Pancreatitis Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Interested in Purchasing this Report? Click here @ https://www.premiummarketinsights.com/buy/TIP00074079?utm_source=OpenPR&utm_medium=10823

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

This release was published on openPR.